预测食管癌患者新辅助化疗或放化疗后病理反应的列线图 - Suppr

Nomogram for Predicting Pathologic Response Following Neoadjuvant Chemotherapy or Chemoradiotherapy in Patients with Esophageal Cancer.

作者信息

Ribeiro Ulysses

机构信息

Department of Gastroenterology, Instituto do Cancer do Estado de São Paulo, Hospital das Clinicas, Faculdade de Medicina, Universidade de São Paulo (ICESP- HCFMUSP), São Paulo, Brazil.

出版信息

Ann Surg Oncol. 2023 Apr;30(4):1945-1947. doi: 10.1245/s10434-023-13133-y. Epub 2023 Jan 30.

DOI:10.1245/s10434-023-13133-y

PMID:36715858

Abstract

摘要

相似文献

Nomogram for Predicting Pathologic Response Following Neoadjuvant Chemotherapy or Chemoradiotherapy in Patients with Esophageal Cancer.预测食管癌患者新辅助化疗或放化疗后病理反应的列线图

Ann Surg Oncol. 2023 Apr;30(4):1945-1947. doi: 10.1245/s10434-023-13133-y. Epub 2023 Jan 30.

Development of a nomogram for the prediction of pathological complete response after neoadjuvant chemoradiotherapy in patients with esophageal squamous cell carcinoma.食管鳞状细胞癌患者新辅助放化疗后病理完全缓解预测列线图的开发

Dis Esophagus. 2017 Feb 1;30(2):1-8. doi: 10.1111/dote.12519.

A prognostic nomogram for overall survival after neoadjuvant radiotherapy or chemoradiotherapy in thoracic esophageal squamous cell carcinoma: a retrospective analysis.胸段食管鳞状细胞癌新辅助放疗或放化疗后总生存的预后列线图：一项回顾性分析

Oncotarget. 2017 Jun 20;8(25):41102-41112. doi: 10.18632/oncotarget.17062.

Validation of a Nomogram Predicting Survival After Trimodality Therapy for Esophageal Cancer.列线图预测食管癌三联治疗后生存的验证。

Ann Thorac Surg. 2018 Nov;106(5):1541-1547. doi: 10.1016/j.athoracsur.2018.05.055. Epub 2018 Jun 19.

Nomogram for predicting the benefit of neoadjuvant chemoradiotherapy for patients with esophageal cancer: a SEER-Medicare analysis.预测食管癌患者新辅助放化疗获益的列线图：一项监测、流行病学和最终结果（SEER）-医疗保险分析

Cancer. 2014 Feb 15;120(4):492-8. doi: 10.1002/cncr.28447. Epub 2013 Nov 5.

Role of Repeat 18F-Fluorodeoxyglucose Positron Emission Tomography Examination in Predicting Pathologic Response Following Neoadjuvant Chemoradiotherapy for Esophageal Adenocarcinoma.18F-氟脱氧葡萄糖正电子发射断层扫描复查在预测食管腺癌新辅助放化疗后病理反应中的作用。

JAMA Surg. 2015 Jun;150(6):555-62. doi: 10.1001/jamasurg.2014.3867.

Nomogram for predicting pathologically complete response after neoadjuvant chemoradiotherapy for oesophageal cancer.预测食管癌新辅助放化疗后病理完全缓解的列线图

Radiother Oncol. 2015 Jun;115(3):392-8. doi: 10.1016/j.radonc.2015.04.028. Epub 2015 Jun 23.

Neoadjuvant chemotherapy or chemoradiotherapy for locally advanced esophageal cancer.局部晚期食管癌的新辅助化疗或放化疗。

Thorac Surg Clin. 2013 Nov;23(4):509-23. doi: 10.1016/j.thorsurg.2013.07.005. Epub 2013 Oct 13.

A nomogram to predict short-term outcome of radiotherapy or chemoradiotherapy based on pre/post-treatment inflammatory biomarkers and their dynamic changes in esophageal squamous cell carcinoma.基于治疗前后炎症生物标志物及其在食管鳞癌中的动态变化，建立预测放疗或放化疗短期疗效的列线图。

Int Immunopharmacol. 2021 Jan;90:107178. doi: 10.1016/j.intimp.2020.107178. Epub 2020 Nov 18.

Detecting interval metastases and response assessment using 18F-FDG PET/CT after neoadjuvant chemoradiotherapy for esophageal cancer.18F-FDG PET/CT 检测食管癌新辅助放化疗后间隔转移和疗效评估。

Clin Nucl Med. 2014 Oct;39(10):862-7. doi: 10.1097/RLU.0000000000000517.

引用本文的文献

Analysis of Recurrence Sites in Esophageal Squamous Cell Carcinoma after Neoadjuvant Chemoradiation with Elective Nodal Irradiation: Insights for Radiation Field Optimization.新辅助放化疗联合选择性淋巴结照射后食管鳞状细胞癌复发部位分析：对放射野优化的启示

Ann Surg Oncol. 2025 Jun 24. doi: 10.1245/s10434-025-17708-9.

Prediction of Post-Stroke Cognitive Impairment Based on Iron Metabolism Parameters: Results From A Prospective Study.基于铁代谢参数的脑卒中后认知障碍预测：一项前瞻性研究的结果

Mol Neurobiol. 2025 Jun 13. doi: 10.1007/s12035-025-05142-7.

Analysis of influencing factors and construction of risk prediction model for postoperative thrombocytopenia in critically ill patients with heart disease.分析心脏病重症患者术后血小板减少症的影响因素并构建风险预测模型。

J Cardiothorac Surg. 2024 Sep 5;19(1):516. doi: 10.1186/s13019-024-03017-x.

本文引用的文献

ASO Author Reflections: Prediction of the Response to Neoadjuvant Therapy by Patients with Esophageal Squamous Cell Carcinoma.ASO作者反思：食管鳞状细胞癌患者对新辅助治疗反应的预测

Ann Surg Oncol. 2023 Apr;30(4):2186-2187. doi: 10.1245/s10434-022-12962-7. Epub 2022 Dec 20.

Immuno-genomic profiling of biopsy specimens predicts neoadjuvant chemotherapy response in esophageal squamous cell carcinoma.免疫基因组分析活检标本预测食管鳞癌新辅助化疗反应。

Cell Rep Med. 2022 Aug 16;3(8):100705. doi: 10.1016/j.xcrm.2022.100705. Epub 2022 Aug 8.

A clinical nomogram for predicting tumor regression grade in esophageal squamous-cell carcinoma treated with immune neoadjuvant immunotherapy.用于预测接受免疫新辅助免疫治疗的食管鳞状细胞癌肿瘤退缩分级的临床列线图。

Ann Transl Med. 2022 Jan;10(2):102. doi: 10.21037/atm-22-78.

A validated nomogram integrating hematological indicators to predict response to neoadjuvant therapy in esophageal squamous cell carcinoma patients.一种整合血液学指标以预测食管鳞状细胞癌患者新辅助治疗反应的有效列线图。

Ann Transl Med. 2021 Apr;9(8):703. doi: 10.21037/atm-21-1628.

Assessment of Intratumoral and Peritumoral Computed Tomography Radiomics for Predicting Pathological Complete Response to Neoadjuvant Chemoradiation in Patients With Esophageal Squamous Cell Carcinoma.评估食管癌新辅助放化疗后病理完全缓解的肿瘤内和肿瘤周围 CT 放射组学特征。

JAMA Netw Open. 2020 Sep 1;3(9):e2015927. doi: 10.1001/jamanetworkopen.2020.15927.

Prealbumin-to-Globulin Ratio Can Predict the Chemotherapy Outcomes and Prognosis of Patients with Gastric Cancer Receiving First-Line Chemotherapy.前白蛋白与球蛋白比值可预测接受一线化疗的胃癌患者的化疗结局和预后。

J Immunol Res. 2020 Aug 5;2020:6813176. doi: 10.1155/2020/6813176. eCollection 2020.

The value of cellular components of blood in the setting of trimodal therapy for esophageal cancer.三模态疗法治疗食管癌时血液细胞成分的价值。

J Surg Oncol. 2020 Apr;121(5):784-794. doi: 10.1002/jso.25778. Epub 2019 Nov 24.

Prognostic Value of Tumor Regression Grade Based on Ryan Score in Squamous Cell Carcinoma and Adenocarcinoma of Esophagus.基于 Ryan 评分的肿瘤退缩分级对食管鳞癌和腺癌的预后价值。

Ann Surg Oncol. 2020 Apr;27(4):1241-1247. doi: 10.1245/s10434-019-07967-8. Epub 2019 Oct 29.

Induction therapy before surgery improves survival in patients with clinical T3N0 esophageal cancer: a nationwide study in Taiwan.术前诱导治疗可提高临床T3N0期食管癌患者的生存率：台湾的一项全国性研究。

Dis Esophagus. 2017 Dec 1;30(12):1-7. doi: 10.1093/dote/dox103.

Novel Calculator to Estimate Overall Survival Benefit from Neoadjuvant Chemoradiation in Patients with Esophageal Adenocarcinoma.用于评估食管腺癌患者新辅助放化疗总生存获益的新型计算器

J Am Coll Surg. 2017 May;224(5):884-894e1. doi: 10.1016/j.jamcollsurg.2017.01.043. Epub 2017 Jan 29.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Nomogram for Predicting Pathologic Response Following Neoadjuvant Chemotherapy or Chemoradiotherapy in Patients with Esophageal Cancer.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献

本文引用的文献